67
A U.S. Centers for Disease Control and Prevention (CDC) advisory panel met on Tuesday to come up with a recommendation on whether updated COVID-19 shots approved by the government should be used broadly or targeted to specific at-risk populations, setting the stage for the launch of a re-vaccination campaign.
The CDC advisers are preparing to decide on whether to recommend that everyone ages 6 months and older receive a dose of the shots – and signaled that they were leaning toward such a broad use. The U.S. Food and Drug Administration (FDA) on Monday authorized updated COVID vaccines made by Pfizer (PFE.N) and its German partner BioNTech (22UAy.DE) as well as by Moderna (MRNA.O). Novavax (NVAX.O) said the FDA was still reviewing its shot.
